Liat Hayardeny Nissimov - 18 Mar 2026 Form 3 Insider Report for Galmed Pharmaceuticals Ltd. (GLMD)

Role
Chief Scientific Officer
Signature
/s/ Liat Hayardeny Nissimov
Issuer symbol
GLMD
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 07:45:45 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Nissimov Brueck Liat Chief Scientific Officer C/O MEITAR LAW OFFICES, 16 ABBA HILLEL SILVER RD., RAMAT GAN, ISRAEL /s/ Liat Hayardeny Nissimov 18 Mar 2026 0002109552

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GLMD Options to Purchase Ordinary Shares 18 Mar 2026 Ordinary Shares 222 $68.40 Direct
holding GLMD Options to Purchase Ordinary Shares 18 Mar 2026 Ordinary Shares 222 $68.40 Direct
holding GLMD Options to Purchase Ordinary Shares 18 Mar 2026 Ordinary Shares 222 $68.40 Direct
holding GLMD Options to Purchase Ordinary Shares 18 Mar 2026 Ordinary Shares 181 $68.40 Direct
holding GLMD Options to Purchase Ordinary Shares 18 Mar 2026 Ordinary Shares 153 $68.40 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.